Application 021345
- Type
- NDA
- Sponsor
- MYLAN IRELAND LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ARIXTRA | FONDAPARINUX SODIUM | INJECTABLE;SUBCUTANEOUS | 2.5MG/0.5ML | Yes | Yes |
| 002 | ARIXTRA | FONDAPARINUX SODIUM | INJECTABLE;SUBCUTANEOUS | 5MG/0.4ML | Yes | Yes |
| 003 | ARIXTRA | FONDAPARINUX SODIUM | INJECTABLE;SUBCUTANEOUS | 7.5MG/0.6ML | Yes | Yes |
| 004 | ARIXTRA | FONDAPARINUX SODIUM | INJECTABLE;SUBCUTANEOUS | 10MG/0.8ML | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021345-001 | ARIXTRA | FONDAPARINUX SODIUM | 2.5MG/0.5ML (2.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | AP | RLD, RS | 2001-12-07 |
| N021345-002 | ARIXTRA | FONDAPARINUX SODIUM | 5MG/0.4ML (5MG/0.4ML) | SOLUTION / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 |
| N021345-003 | ARIXTRA | FONDAPARINUX SODIUM | 7.5MG/0.6ML (7.5MG/0.6ML) | SOLUTION / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 |
| N021345-004 | ARIXTRA | FONDAPARINUX SODIUM | 10MG/0.8ML (10MG/0.8ML) | SOLUTION / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N021345-001 | AP |
| N021345-002 | AP |
| N021345-003 | AP |
| N021345-004 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N021345-001 | ARIXTRA | 2.5MG/0.5ML (2.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | AP | RLD, RS | 2001-12-07 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021345-002 | ARIXTRA | 5MG/0.4ML (5MG/0.4ML) | SOLUTION / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021345-003 | ARIXTRA | 7.5MG/0.6ML (7.5MG/0.6ML) | SOLUTION / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021345-004 | ARIXTRA | 10MG/0.8ML (10MG/0.8ML) | SOLUTION / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N021345-001 | ARIXTRA | 2.5MG/0.5ML | SOLUTION / SUBCUTANEOUS | AP | RLD, RS | 2001-12-07 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021345-002 | ARIXTRA | 5MG/0.4ML | SOLUTION / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021345-003 | ARIXTRA | 7.5MG/0.6ML | SOLUTION / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021345-004 | ARIXTRA | 10MG/0.8ML | SOLUTION / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021345-001 | ARIXTRA | 2.5MG/0.5ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2001-12-07 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021345-002 | ARIXTRA | 5MG/0.4ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021345-003 | ARIXTRA | 7.5MG/0.6ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021345-004 | ARIXTRA | 10MG/0.8ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N021345-001 | ARIXTRA | 2.5MG/0.5ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2001-12-07 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021345-002 | ARIXTRA | 5MG/0.4ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021345-003 | ARIXTRA | 7.5MG/0.6ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021345-004 | ARIXTRA | 10MG/0.8ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021345-001 | ARIXTRA | 2.5MG/0.5ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2001-12-07 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021345-002 | ARIXTRA | 5MG/0.4ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021345-003 | ARIXTRA | 7.5MG/0.6ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021345-004 | ARIXTRA | 10MG/0.8ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021345-001 | ARIXTRA | 2.5MG/0.5ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2001-12-07 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021345-002 | ARIXTRA | 5MG/0.4ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021345-003 | ARIXTRA | 7.5MG/0.6ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021345-004 | ARIXTRA | 10MG/0.8ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021345-001 | ARIXTRA | 2.5MG/0.5ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2001-12-07 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021345-002 | ARIXTRA | 5MG/0.4ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021345-003 | ARIXTRA | 7.5MG/0.6ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021345-004 | ARIXTRA | 10MG/0.8ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021345-001 | ARIXTRA | 2.5MG/0.5ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2001-12-07 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021345-002 | ARIXTRA | 5MG/0.4ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021345-003 | ARIXTRA | 7.5MG/0.6ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021345-004 | ARIXTRA | 10MG/0.8ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021345-001 | ARIXTRA | 2.5MG/0.5ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2001-12-07 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021345-002 | ARIXTRA | 5MG/0.4ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021345-003 | ARIXTRA | 7.5MG/0.6ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021345-004 | ARIXTRA | 10MG/0.8ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021345-001 | ARIXTRA | 2.5MG/0.5ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2001-12-07 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021345-002 | ARIXTRA | 5MG/0.4ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021345-003 | ARIXTRA | 7.5MG/0.6ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021345-004 | ARIXTRA | 10MG/0.8ML | INJECTABLE / SUBCUTANEOUS | AP | RLD, RS | 2004-05-28 | d8e5a09893c0… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N021345-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021345-002 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021345-003 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021345-004 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N021345-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021345-002 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021345-003 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021345-004 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021345-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021345-002 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021345-003 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021345-004 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N021345-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021345-002 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021345-003 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021345-004 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021345-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021345-002 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021345-003 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021345-004 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021345-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021345-002 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021345-003 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021345-004 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021345-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021345-002 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021345-003 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021345-004 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021345-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021345-002 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021345-003 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021345-004 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021345-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021345-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021345-003 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021345-004 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021345-001 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021345-002 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021345-003 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021345-004 | AP | 1 | d8e5a09893c0… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Arixtra | FONDAPARINUX SODIUM | Mylan Institutional LLC | d3b30c68-cf45-4b46-8ba6-72090f7ba01a | 2024-12-10 | Boxed warning, Warnings, Adverse reactions | 021345 NDA021345 67457-592 67457-594 67457-595 67457-593 |
| Fondaparinux Sodium | FONDAPARINUX SODIUM | Mylan Institutional LLC | 4b65f642-87f7-4da5-a9c9-02cd1f8d9d16 | 2020-08-15 | Boxed warning, Warnings, Adverse reactions | 021345 NDA021345 67457-584 67457-582 67457-583 67457-585 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 67457-582 | Fondaparinux Sodium | fondaparinux sodium | Mylan Institutional LLC | NDA AUTHORIZED GENERIC | Current |
| 67457-582 | Fondaparinux Sodium | fondaparinux sodium | Mylan Institutional LLC | NDA AUTHORIZED GENERIC | Current |
| 67457-582 | Fondaparinux Sodium | fondaparinux sodium | Mylan Institutional LLC | NDA AUTHORIZED GENERIC | Current |
| 67457-583 | Fondaparinux Sodium | fondaparinux sodium | Mylan Institutional LLC | NDA AUTHORIZED GENERIC | Current |
| 67457-583 | Fondaparinux Sodium | fondaparinux sodium | Mylan Institutional LLC | NDA AUTHORIZED GENERIC | Current |
| 67457-583 | Fondaparinux Sodium | fondaparinux sodium | Mylan Institutional LLC | NDA AUTHORIZED GENERIC | Current |
| 67457-584 | Fondaparinux Sodium | fondaparinux sodium | Mylan Institutional LLC | NDA AUTHORIZED GENERIC | Current |
| 67457-584 | Fondaparinux Sodium | fondaparinux sodium | Mylan Institutional LLC | NDA AUTHORIZED GENERIC | Current |
| 67457-584 | Fondaparinux Sodium | fondaparinux sodium | Mylan Institutional LLC | NDA AUTHORIZED GENERIC | Current |
| 67457-585 | Fondaparinux Sodium | fondaparinux sodium | Mylan Institutional LLC | NDA AUTHORIZED GENERIC | Current |
| 67457-585 | Fondaparinux Sodium | fondaparinux sodium | Mylan Institutional LLC | NDA AUTHORIZED GENERIC | Current |
| 67457-585 | Fondaparinux Sodium | fondaparinux sodium | Mylan Institutional LLC | NDA AUTHORIZED GENERIC | Current |
| 67457-592 | Arixtra | fondaparinux sodium | Mylan Institutional LLC | NDA | Current |
| 67457-592 | Arixtra | fondaparinux sodium | Mylan Institutional LLC | NDA | Current |
| 67457-592 | Arixtra | fondaparinux sodium | Mylan Institutional LLC | NDA | Current |
| 67457-592 | Arixtra | fondaparinux sodium | Mylan Institutional LLC | NDA | Current |
| 67457-592 | Arixtra | fondaparinux sodium | Mylan Institutional LLC | NDA | Current |
| 67457-592 | Arixtra | fondaparinux sodium | Mylan Institutional LLC | NDA | Current |
| 67457-593 | Arixtra | fondaparinux sodium | Mylan Institutional LLC | NDA | Current |
| 67457-593 | Arixtra | fondaparinux sodium | Mylan Institutional LLC | NDA | Current |
| 67457-593 | Arixtra | fondaparinux sodium | Mylan Institutional LLC | NDA | Current |
| 67457-593 | Arixtra | fondaparinux sodium | Mylan Institutional LLC | NDA | Current |
| 67457-593 | Arixtra | fondaparinux sodium | Mylan Institutional LLC | NDA | Current |
| 67457-593 | Arixtra | fondaparinux sodium | Mylan Institutional LLC | NDA | Current |
| 67457-594 | Arixtra | fondaparinux sodium | Mylan Institutional LLC | NDA | Current |
| 67457-594 | Arixtra | fondaparinux sodium | Mylan Institutional LLC | NDA | Current |
| 67457-594 | Arixtra | fondaparinux sodium | Mylan Institutional LLC | NDA | Current |
| 67457-594 | Arixtra | fondaparinux sodium | Mylan Institutional LLC | NDA | Current |
| 67457-594 | Arixtra | fondaparinux sodium | Mylan Institutional LLC | NDA | Current |
| 67457-594 | Arixtra | fondaparinux sodium | Mylan Institutional LLC | NDA | Current |
| 67457-595 | Arixtra | fondaparinux sodium | Mylan Institutional LLC | NDA | Current |
| 67457-595 | Arixtra | fondaparinux sodium | Mylan Institutional LLC | NDA | Current |
| 67457-595 | Arixtra | fondaparinux sodium | Mylan Institutional LLC | NDA | Current |
| 67457-595 | Arixtra | fondaparinux sodium | Mylan Institutional LLC | NDA | Current |
| 67457-595 | Arixtra | fondaparinux sodium | Mylan Institutional LLC | NDA | Current |
| 67457-595 | Arixtra | fondaparinux sodium | Mylan Institutional LLC | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 80806 | SUPPL | 2025-01-02 |
| 80753 | SUPPL | 2024-12-27 |
| 64554 | SUPPL | 2020-09-11 |
| 64416 | SUPPL | 2020-08-26 |
| 61301 | SUPPL | 2019-12-17 |
| 61280 | SUPPL | 2019-12-16 |
| 49485 | SUPPL | 2017-08-21 |
| 49461 | SUPPL | 2017-08-18 |
| 36710 | SUPPL | 2014-07-17 |
| 5108 | SUPPL | 2014-07-17 |
| 36709 | SUPPL | 2013-09-17 |
| 5107 | SUPPL | 2013-09-13 |
| 15239 | SUPPL | 2010-04-04 |
| 27541 | SUPPL | 2010-03-31 |
| 27542 | SUPPL | 2009-12-31 |
| 15240 | SUPPL | 2009-12-30 |
| 27540 | SUPPL | 2009-11-25 |
| 15238 | SUPPL | 2009-09-18 |
| 27539 | SUPPL | 2008-10-21 |
| 36708 | SUPPL | 2005-05-27 |
| 5106 | SUPPL | 2005-05-27 |
| 27538 | SUPPL | 2004-06-01 |
| 15237 | SUPPL | 2004-06-01 |
| 15236 | SUPPL | 2004-06-01 |
| 5105 | SUPPL | 2004-06-01 |
| 42114 | ORIG | 2004-05-27 |
| 27537 | SUPPL | 2003-06-22 |
| 15235 | SUPPL | 2003-06-22 |
| 27536 | SUPPL | 2002-12-04 |
| 15234 | SUPPL | 2002-12-04 |
| 15233 | ORIG | 2001-12-07 |
| 5104 | ORIG | 2001-12-07 |